Conference
A randomized phase III study of duration of anti-PD-1 therapy in metastatic melanoma (STOP-GAP): Canadian Clinical Trials Group study (CCTG) ME.13.
Authors
Baetz TD; Song X; Ernst DS; McWhirter E; Petrella TM; Savage KJ; Smylie M; Wong R; Lee CW; Look Hong N
Volume
36
Pagination
pp. tps9600-tps9600
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
May 20, 2018
DOI
10.1200/jco.2018.36.15_suppl.tps9600
Conference proceedings
Journal of Clinical Oncology
Issue
15_suppl
ISSN
0732-183X